Portfolio of Marijuana (Cannabis) Pharma Stocks Traded on U.S. Exchanges
Here is a table of 14 cannabis stocks that are developing cannabis compound medicines.
|14 Cannabis Pharma Stocks|
Stock & Price Chart
|Corbus Pharmaceuticals Holdings||CRBP|
|OWC Pharmaceutical Research||OWCP|
|Price data from Quandl as of most recent close.|
The 7 stocks included in the portfolio
computations are: ABBV, ARNA, CARA, CRBP, GWPH, INSY and ZYNE. The current value of the portfolio assumes that $1,428.57 was invested (total of $10,000) in each stock at its closing monthly price for the current date in 2016. All prices are adjusted for splits and dividends. The 7 stocks excluded from the portfolio computations because of insufficient price data are: AXIM, CNBX, GBLX, OWCP, PMCB, CNAB and VBIO.
To inspect the performance of the Cannabis Pharma Stocks portfolio, see the chart of portfolio below. Portfolio values are computed using monthly closes for stocks from Quandl.
The current value of a $10,000 investment is $14,968. The percent return is 49.68%. The annualized return is 12.21%.